Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | TSC2 |
| Variant | L1750Afs*25 |
| Impact List | frameshift |
| Protein Effect | loss of function - predicted |
| Gene Variant Descriptions | TSC2 L1750Afs*25 indicates a shift in the reading frame starting at amino acid 1750 and terminating 25 residues downstream causing a premature truncation of the 1807 amino acid Tsc2 protein (UniProt.org). L1750Afs*25 results in increased mTORC1 signaling in culture (PMID: 22903760), and therefore, is predicted to lead to a loss of Tsc2 protein function. |
| Associated Drug Resistance | |
| Category Variants Paths |
TSC2 mutant TSC2 inact mut TSC2 L1750Afs*25 |
| Transcript | NM_000548.5 |
| gDNA | chr16:g.2088313dupG |
| cDNA | c.5247dupG |
| Protein | p.L1750Afs*25 |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_000548.4 | chr16:g.2088313dupG | c.5247dupG | p.L1750Afs*25 | RefSeq | GRCh38/hg38 |
| NM_000548 | chr16:g.2088313dupG | c.5247dupG | p.L1750Afs*25 | RefSeq | GRCh38/hg38 |
| NM_000548.5 | chr16:g.2088313dupG | c.5247dupG | p.L1750Afs*25 | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|